Constitutive phosphoinositide 3-kinase activation in acute myeloid leukemia is not due to p110δ mutations [11]

Leukemia

Volumn 20, Issue 2, 2006, Pages 374-376

  Cornillet Lefebvre, P ^a,b   Cuccuini, W ^a,b   Bardet, V ^c,d   Tamburini, J ^c,d   Gillot, L ^a,b   Ifrah, N ^e,f   Nguyen, P ^a,b   Dreyfus, F ^c,d   Mayeux, P ^c,d   Lacombe, C ^c,d   Bouscary, D ^c,d  

^a REIMS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d CHU Angers ^*  (France)

^e ANGERS UNIVERSITY HOSPITAL   (France)

^f UPRES EA 3863 UFR Médecine Angers   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FLT3 LIGAND; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P110; RAS PROTEIN; SERINE; STEM CELL FACTOR RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW; CLINICAL ARTICLE; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME PHOSPHORYLATION; EXON; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; HUMAN; KARYOTYPE; LETTER; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 31444434588     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404054     Document Type: Letter

References (9)

1. Xu Q, Simpson SE, Scialla TJ, Bagg A, Carroll M. Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood 2003; 102: 972-980.
2. Vanhaesebroeck B, Leevers SJ, Panayotou G, Waterfield MD. Phosphoinositide 3-kinases: A conserved family of signal transducers. Trends Biochem Sci 1997; 22: 267-272.
3. Vanhaesebroeck B, Welham MJ, Kotani K, Stein R, Warne PH, Zvelebil MJ et al. P110delta, a novel phosphoinositide 3-kinase in leukocytes. Proc Natl Acad Sci USA 1997; 94: 4330-4335.
4. Sujobert P, Bardet V, Cornillet-Lefebvre P, Hayflick JS, Prie N, Verdier F et al. Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia. Blood 2005; 106: 1063-1066.
5. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 2004; 304: 554.
6. Samuels Y, Diaz Jr LA, Schmidt-Kittler O, Cummins JM, Delong L, Cheong I et al. Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 2005; 7: 561-573.
7. Kang S, Bader AG, Vogt PK. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci USA 2005; 102: 802-807.
8. Zheng R, Levis M, Piloto O, Brown P, Baldwin BR, Gorin NC et al. FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells. Blood 2004; 103: 267-274.
9. Ozeki K, Kiyoi H, Hirose Y, Iwai M, Ninomiya M, Kodera Y et al. Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia. Blood 2004; 103: 1901-1908.